Mucoadhesive Drug Delivery (Buccal/Nasal/Pulmonary) MCQs With Answer

Mucoadhesive Drug Delivery (Buccal/Nasal/Pulmonary) MCQs With Answer

This collection of multiple-choice questions is designed for M.Pharm students studying Novel Drug Delivery Systems. It focuses on mucoadhesive drug delivery applied to buccal, nasal and pulmonary routes, emphasizing mechanisms of mucoadhesion, polymer selection, formulation strategies, evaluation techniques and clinical challenges. Questions cover fundamental theories (diffusion, adsorption, wetting), commonly used polymers (chitosan, carbomers, HPMC), route-specific barriers (mucociliary clearance, macrophage uptake), and analytical/quality considerations (aerodynamic particle size, gamma scintigraphy). Use these MCQs to test understanding, prepare for exams, and reinforce formulation decision-making for designing effective mucoadhesive systems for local and systemic delivery.

Q1. What is the best concise definition of mucoadhesion in drug delivery?

• Interaction between drug molecules and epithelial cell receptors
• Adhesion of a formulation to mucosal surfaces mediated by specific interaction between polymer and mucus
• Penetration of drug through the skin into systemic circulation
• Formation of covalent bonds between polymer and tissue proteins

Correct Answer: Adhesion of a formulation to mucosal surfaces mediated by specific interaction between polymer and mucus

Q2. Which theory of mucoadhesion explains the interpenetration of polymer chains with mucus glycoprotein chains?

• Electronic theory
• Wetting theory
• Diffusion (interpenetration) theory
• Fracture theory

Correct Answer: Diffusion (interpenetration) theory

Q3. Which commonly used mucoadhesive polymer is cationic and also acts as a permeation enhancer by opening tight junctions?

• Carbopol (polyacrylic acid)
• Hydroxypropyl methylcellulose (HPMC)
• Chitosan
• Polyvinyl alcohol (PVA)

Correct Answer: Chitosan

Q4. What is a primary systemic advantage of buccal mucoadhesive delivery compared with oral tablets?

• Shorter onset of action than intravenous injection
• Avoidance of first-pass hepatic metabolism
• Greater gastric stability of peptides
• Higher dose capacity than oral tablets

Correct Answer: Avoidance of first-pass hepatic metabolism

Q5. What is the major physiological limitation that reduces residence time of drugs in the nasal cavity?

• Lack of blood vessels
• Mucociliary clearance
• Low surface area
• Inability of nasal epithelium to absorb small molecules

Correct Answer: Mucociliary clearance

Q6. In the conducting airways, which clearance mechanism is primarily responsible for removing inhaled particles and limits pulmonary residence?

• Alveolar transcytosis
• Mucociliary escalator
• Renal excretion
• Enzymatic degradation in pleura

Correct Answer: Mucociliary escalator

Q7. Which in vitro method directly measures the force required to detach a mucoadhesive formulation from mucosal tissue?

• Wash-off test
• Tensile (detachment) test using a texture analyzer
• Rheological synergism study
• Ex vivo permeability assay

Correct Answer: Tensile (detachment) test using a texture analyzer

Q8. Why is an impermeable backing layer included in many buccal mucoadhesive patches?

• To increase the patch flexibility in the oral cavity
• To promote bidirectional release into saliva and mucosa
• To provide taste masking for bitter drugs
• To achieve unidirectional drug release toward the mucosa and minimize loss to the oral cavity

Correct Answer: To achieve unidirectional drug release toward the mucosa and minimize loss to the oral cavity

Q9. Which property of chitosan contributes to its mucoadhesive performance on negatively charged mucus?

• Hydrophobicity that repels mucin
• Cationic charge that enables electrostatic interaction with mucin
• Strong covalent bonding with mucosal proteins
• Ability to crystallize at physiological pH

Correct Answer: Cationic charge that enables electrostatic interaction with mucin

Q10. Carbopol (carbomer) exhibits strong mucoadhesion primarily because it:

• Is a cationic polysaccharide
• Forms covalent bonds with mucin glycoproteins
• Contains polyacrylic acid groups that form hydrogen bonds and swell to entangle with mucus
• Is highly hydrophobic and repels water to adhere

Correct Answer: Contains polyacrylic acid groups that form hydrogen bonds and swell to entangle with mucus

Q11. How does increasing polymer molecular weight generally affect mucoadhesion (within practical formulation limits)?

• It decreases mucoadhesive strength due to poor chain mobility
• It increases mucoadhesion by enhancing chain entanglement and interpenetration
• It has no effect on mucoadhesion
• It always causes irritation and reduces adhesion

Correct Answer: It increases mucoadhesion by enhancing chain entanglement and interpenetration

Q12. Which imaging technique is commonly used in vivo to study nasal deposition and clearance of formulations?

• Scanning electron microscopy (SEM)
• Gamma scintigraphy
• Atomic force microscopy (AFM)
• FTIR spectroscopy

Correct Answer: Gamma scintigraphy

Q13. For effective deep lung (alveolar) deposition of inhaled particles, the optimal aerodynamic diameter generally lies within which range?

• 10–20 µm
• 5–10 µm
• 1–5 µm
• <0.1 µm

Correct Answer: 1–5 µm

Q14. Buccal mucoadhesive patches intended for sustained systemic delivery commonly aim for which drug release profile to maintain steady plasma levels?

• Burst release followed by immediate elimination
• Zero-order (constant) release
• First-order rapid exponential decay
• Complete release within 5 minutes

Correct Answer: Zero-order (constant) release

Q15. Which excipient is both mucoadhesive and known to act as a permeation enhancer in nasal formulations?

• Poloxamer 407
• Sorbitol
• Chitosan
• Magnesium stearate

Correct Answer: Chitosan

Q16. Compared to sublingual delivery, buccal mucoadhesive delivery is particularly advantageous because it:

• Provides faster onset of action than sublingual
• Allows prolonged contact and sustained drug release at the mucosa
• Requires swallowing frequently for absorption
• Is primarily used only for local anesthetics

Correct Answer: Allows prolonged contact and sustained drug release at the mucosa

Q17. Which polymer is non-ionic and widely used as a mucoadhesive matrix former with good film-forming properties?

• Carbopol (polyacrylic acid)
• Chitosan
• Hydroxypropyl methylcellulose (HPMC)
• Sodium alginate

Correct Answer: Hydroxypropyl methylcellulose (HPMC)

Q18. For nasal and pulmonary formulations, which quality attribute is most critical for determining regional deposition and therapeutic effect?

• Viscosity at 1000 rpm
• Aerodynamic particle size distribution
• Tablet hardness
• pH of the bulk manufacturing solvent

Correct Answer: Aerodynamic particle size distribution

Q19. By which combined mechanism do mucoadhesive polymers increase the residence time of a formulation on mucosal surfaces?

• Covalent cross-linking with mucin and enzymatic degradation
• Interpenetration of polymer chains with mucus and formation of non-covalent secondary bonds (hydrogen, electrostatic)
• Complete impermeability to water and prevention of swelling
• Immediate dissolution followed by systemic uptake

Correct Answer: Interpenetration of polymer chains with mucus and formation of non-covalent secondary bonds (hydrogen, electrostatic)

Q20. Which formulation approach is commonly used to enhance pulmonary retention of drugs using mucoadhesive technology?

• Use of very large particles (>20 µm) to lodge in upper airways
• Mucoadhesive microspheres or nanoparticles incorporated into dry powder inhalers to increase adhesion to airway mucosa
• Formulation as highly volatile sprays to avoid deposition
• Use of immediate-release nebulized solutions without polymers

Correct Answer: Mucoadhesive microspheres or nanoparticles incorporated into dry powder inhalers to increase adhesion to airway mucosa

Download